< Back to search
Filter
1

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

for
Hodgkin Lymphoma, Relapsed or Refractory Hodgkin Lymphoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT03618550

Phase2, Recruiting

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

for
Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma,
Location: New York NY, Salt Lake City UT, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05861050

Phase1, Phase2, Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Valhalla NY, Chapel Hill NC, Jacksonville FL,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase1, Phase2, Recruiting

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

for
Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell,
Location: Philadelphia PA, Miami FL, Buffalo NY, Cleveland OH,
Sponsor: Oncotartis, Inc.

Sex: All

Age: 18+

Code: NCT03921879

Phase1, Recruiting

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: Miami FL, Florence SC, Charleston SC, Cleveland OH,
Sponsor: Adela, Inc

Sex: All

Age: 40+

Code: NCT05366881

Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Avo In R/R And Previously Untreated MCL

for
Mantle Cell Lymphoma, Refractory Lymphoma
Location: Boston MA, Chicago IL
Sponsor: Austin I Kim

Sex: All

Age: 18+

Code: NCT04855695

Phase1, Phase2, Recruiting

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

for
Primary Central Nervous System Lymphoma,
Location: Miami FL
Sponsor: Baptist Health South Florida

Sex: All

Age: 18+

Code: NCT05681195

Phase2, Recruiting

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

for
Non-hodgkin Lymphoma, Hodgkin Lymphoma
Location: Vallhala NY, Gainsville FL
Sponsor: New York Medical College

Sex: All

Age: 3 - 39

Code: NCT05253495

Phase2, Recruiting

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

for
Acute Leukemia of Ambiguous Lineage,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 65

Code: NCT06013423

Phase2, Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

for
Solid Tumors, Lymphoma
Location: Cleveland OH
Sponsor: Spectrum Pharmaceuticals, Inc

Sex: All

Age: 0 - 17

Code: NCT04570423

Phase2, Recruiting

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

for
Acute Leukemia, Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Rochester NY, Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06207123

Phase1, Phase2, Recruiting

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT05876923

Recruiting

Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

for
Lymphoma, T-Cell
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18+

Code: NCT03161223

Phase1, Phase2, Recruiting

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Saint John, Montreal, Ottawa, Winnipeg, Vancouver
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05371808

Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

for
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL),
Location: New Haven CT, New York NY, New Brunswick NJ, Montreal,
Sponsor: Arvinas Inc.

Sex: All

Age: 18+

Code: NCT06393738

Phase1, Recruiting

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

for
Follicular Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06043323

Phase2, Recruiting

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

for
Solid Tumor, Lymphoma
Location: Morristown NJ, Chicago IL
Sponsor: MultiVir, Inc.

Sex: All

Age: 18+

Code: NCT03544723

Phase2, Recruiting

Pilot Imaging Study of Leukemia

for
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia,
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 4 - 70+

Code: NCT03633955

Phase1, Recruiting

Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

for
Primary Central Nervous System Lymphoma,
Location: Boston MA
Sponsor: Lakshmi Nayak, MD

Sex: All

Age: 18+

Code: NCT04906096

Phase2, Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: The Bronx NY, New York NY, Hackensack NJ,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase1, Phase2, Recruiting